Abstract

BackgroundThe COVID-19 pandemic has overburdened the healthcare facilities, which demanded the use of alternative and effective methods for delivering healthcare services. The use of telehealth has become a necessity to provide initial health services.ObjectiveTo identify the pharmaceutical care provided by community pharmacists to suspected high-risk COVID-19 patients using telehealth.MethodsA simulated patient (SP) phoned 100 randomly-selected community pharmacies throughout Lebanon using a standard scenario of uncontrolled diabetes mellitus with typical symptoms of COVID-19. Pharmacists’ responses were compared with pre-defined ideal recommendations using a special form.ResultsThe mean of the retrieved medical information score obtained by the pharmacists was 2.48 ± 2.79 (out of 21), with 34 % of the participants not retrieving any relevant medical data from the SP. The relative patient information, the exposure to COVID-19, and the possible COVID-19 symptoms were not retrieved by 61 %, 70 %, and 41 % of the pharmacists, respectively. Two percent of the pharmacists assured that the SP’s symptoms were related to common cold, while 5 % confirmed that the SP is infected with COVID-19. Notably, 35 % of the pharmacists did not offer any recommendation. Among them, 14 % claimed that they were too busy to respond. Only 39 % of the pharmacists provided an appropriate recommendation by referring the SP to her physician to seek medical attention within 24 h since the SP is a high-risk patient, and 41 % recommended doing a PCR test. Antipyretics, antibiotics, and dietary supplements were recommended by 27 %, 7 %, and 16 % of the pharmacists, respectively. Less than 16 % of the pharmacists recommended using protective measures against COVID-19. In addition, the overall communication skills of the pharmacists were generally below expectations.ConclusionsThis study is the first to assess the quality of pharmaceutical care provided by community pharmacists in the Middle East via Telehealth. An unsatisfactory level of preparedness through means of telehealth technology was evident. This resulted in the quality of pharmaceutical-care services provided to high-risk patients via telehealth to be below expectations. Therefore, health authorities should encourage community pharmacists to effectively adopt telehealth, by providing appropriate training, as well as recognizing their extra efforts with financial compensations, aiming to optimize patients’ health outcomes.

Highlights

  • The COVID-19 pandemic has stretched the capacity of the healthcare systems, increasing demand for life-saving medications, revealing disturbing barriers in patient care access, and exacerbating the shortage of healthcare professionals [1, 2]

  • This study is the first to assess the quality of pharmaceutical care provided by community pharmacists in the Middle East via Telehealth

  • An unsatisfactory level of preparedness through means of telehealth technology was evident. This resulted in the quality of pharmaceutical-care services provided to high-risk patients via telehealth to be below expectations

Read more

Summary

Introduction

The COVID-19 pandemic has stretched the capacity of the healthcare systems, increasing demand for life-saving medications, revealing disturbing barriers in patient care access, and exacerbating the shortage of healthcare professionals [1, 2]. Pharmacists have been working hard to prove and establish themselves as core members in the provision of patient care, and today, amid the pandemic, they have had the opportunity to effectively embrace their role as frontline healthcare providers shifting the concept of the pharmacy profession [5, 6]. Apart from their initial patientcentered role, community pharmacists were involved in controlling the SAR-COV-2 virus transmission, assessing potential COVID-19 carriers, and triaging suspected cases [5, 7, 8]. The use of telehealth has become a necessity to provide initial health services

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.